Yahoo Finance Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services
24 May 2022
Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services
Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical services company, announces it has nearly doubled its US site capacity to better service large-scale clinical trials.
In the last 24 months, Clinigen has seen a large increase in demand from pharmaceutical and biotech companies for its tailored Clinical Supplies Management services including packaging and labelling, comparator drug sourcing, global storage and distribution, and biological sample management. As a result, to ensure the continued delivery of industry-leading services to clients, Clinigen is opening new satellite facilities in Fargo, North Dakota and Malvern, Pennsylvania.
Located near the Company’s existing locations, the two new satellite facilities will allow Clinigen to support the continued growth of its GMP storage and distribution and cold-chain management services, with new walk-in refrigerators and freezers, for 2-8°C, - 20°C, as well as -80°C storage.
Shaun Chilton, Chief Executive Officer, Clinigen, said:
“Throughout the pandemic, we have seen a continued increase in the demand for our clinical services. With many halted trials starting up again and our pipeline continuing to grow, we are as focused as ever on meeting the needs of our clients and providing the high service levels that are at the heart of why clients choose to work with Clinigen. This investment demonstrates our continued commitment to our clients and reflects their trust in our tailored clinical services offering.”
- Ends –
Contact details
Clinigen Limited | +44 (0) 1932 824 091 |
Rob Fox, VP Corporate Development | |
|
|
Consilium Strategic Communications |
|
|
|
Notes to Editors
About Clinigen
Clinigen is a global, specialist pharmaceutical services company focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time. The Group operates from sites in North America, Europe, Africa and the Asia Pacific. Clinigen has more than 1,000 employees across five continents in 14 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. The Group works with 31 of the top 50 pharmaceutical companies providing access across more than 120 countries.
For more information on Clinigen, please visit http://www.clinigen.com
